Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
Phone(617) 357-7474


Fund VI, 1/2011 $66M


535 Boylston Street
Suite 402
Boston, MA, 02116
Malibu, USA
30765 Pacific Coast Highway
Suite 370
Malibu, CA, 90265


Director and General Partner
Venture Partner
Managing General Partner
Senior General Partner
Founding General Partner
Senior General Partner
Venture Partner
Show All People


Oxford Bioscience Partners

Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stage situations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.

Recent Milestones


Company Date Round Size Participants
Affinium Pharmaceuticals 9/2013Debt$11.9M3
Dicerna Pharmaceuticals 7/2013Series C$60M9
Mitralign 5/2012Series D$35M6
Glori Energy 1/2012Series C$20M6
CardioFocus 2/2011Series C$30.6M9
SuperDimension 9/2010Venture Round$24.8M4
Tragara 4/2010Series B$5M5
Seahorse Bioscience 3/2010Series D$5M7
Molecular Biometrics 1/2010Series B$12.5M3
CircuLite 1/2010Series C$32.5M4
Cambrios Technologies 11/2009Series D$14.5M14
Coherex Medical 10/2009Series B$16.5M3
VaxInnate 6/2009Series D$30M7
Elixir Pharmaceuticals 5/2009Series D$12M5
Claros Diagnostics 3/2009Series B$4M4
Seahorse Bioscience 3/2009Series D$6M7
Pathway Medical Technologies 3/2009Series D$42.5M5
Melinta 1/2009Private Equity$25M8
Luca Technologies 12/2008Series C$75.9M3
Radius Health 11/2008Series C$15M7
BrainCells 3/2008Series B$30M6
Laboratory Partners 1/2008Series D$16M3
Luca Technologies 10/2007Series B$20M3
Intechra Holdings 5/2007Series C$30M5
Radius Health 4/2007Series B$57.5M6
Elixir Pharmaceuticals 11/2006Series C$46M6
Solstice Neurosciences 11/2006Series B$85M5
VaxInnate 10/2006Series C$40M6
FlowMedica 11/2005Series D$15M5
Solstice Neurosciences 7/2005Venture Round$8M4
Cambrios Technologies 2/2005Series B$12M8
Ensemble Discovery 5/2004Series A$15M3



  1. Oxford Bioscience reported to raise $66M in new fund ( [edit]
  2. Oxford Bioscience reported to raise $66M in new fund ( [edit]
  3. Affinium Pharmaceuticals raises $12 million in debt financing ( [edit]
  4. Dicerna Pharmaceuticals Raises $60M In Series C Financing ( [edit]
  5. Mitralign Closes $35M in Series D Financing ( [edit]
  6. Glori Energy Raises $20 Million ( [edit]
  7. CardioFocus, Inc. Raises $30.6 Million in Private Financing ( [edit]
  8. superDimension Raises $24.8 Million in Debt and Equity Financing ( [edit]
  9. Tragara Pharmaceuticals, Inc.: Series B $5M ( [edit]
  10. Seahorse Bioscience, Inc.: Series D $5M ( [edit]
  11. Molecular Biometrics Closes $12.5M Series B Equity Funding ( [edit]
  12. CircuLite Completes $32.5M Series C Financing ( [edit]
  13. Cambrios lands $14.5M for electronic display components ( [edit]
  14. Coherex Medical, Inc.: Series B $16.5M ( [edit]
  15. VaxInnate Corp., Series D $30M ( [edit]
  16. Elixir Pharmaceuticals, Inc.: Series D $12M ( [edit]
  17. Claros Diagnostics Raises $4 Million ( [edit]
  18. Seahorse Bioscience lands $6M, buys BioProcessors Corp ( [edit]
  19. Pathway Medical lands generous $40M to treat arterial disease ( [edit]
  20. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing ( [edit]
  21. Luca Technologies Raises $76M for Coal Biotech ( [edit]
  22. Radius adds $15M to third venture round ( [edit]
  23. BrainCells raises $30M ( [edit]
  24. Clinical diagnostics maker Laboratory Partners pulls in $16M ( [edit]
  25. Luca Technologies Raises $20M for Cleaner Coal ( [edit]
  26. Intechra, electronics recycler, gets $30M. ( [edit]
  27. Radius Raises $57.5 Million in Second Private Financing Round ( [edit]
  28. Elixir raises $46M for fountain of youth ( [edit]
  29. Solstice Neurosciences Raises $85 Million in Private Financing ( [edit]
  30. VaxInnate Secures $40 Million Series C Financing. ( [edit]
  31. FlowMedica Inc., Completes $15 Million Series D Financing ( [edit]
  32. EDGAR [edit]
  33. Cambrios Technology Announces $12 Million Series B Round ( [edit]
Edit This Page
Last Edited 3/8/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy